Serum procalcitonin levels associate with Clostridioides difficile infection in patients with inflammatory bowel disease.
Mohammad AbdehaghShahrbanoo Keshavarz Azizi RaftarHamidreza HouriBanafsheh NadalianFahimeh AzimiradMeysam OlfatifarOme Kolsoum Nasir ShoeibiAbbas YadegarShabman ShahrokhMehran Mahdavi RoshanHamid Asadzadeh AghdaeiMohammad Reza ZaliPublished in: BMC infectious diseases (2021)
Our results indicate that procalcitonin level can be a good candidate biomarker for assessing the CDI in IBD patients. Further studies are required to decipher whether procalcitonin can predict CDI therapy or its recurrence.